The completion of construction will be followed by GMP certification at the provincial level, according to the company.
The 53,000mt2 pre-extraction plant will perform initial processing of traditional Chinese medicine (TCM) raw material, separation using alcohol or water precipitation, filtration, centrifugation, concentration and purification of TCM pharmaceutical ingredients, which will be further processed to manufacture modernized traditional Chinese medicine (mTCM) at the formulation unit.
Designed and constructed according to the latest GMP standards, the combined QLF plant is likely to save the current capacity saturation at TPI’s facilities.